Axa’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-86,787
| Closed | -$2.41M | – | 1335 |
|
|
2019
Q2 | $2.41M | Sell |
86,787
-16,000
| -16% | -$444K | 0.01% | 812 |
|
|
2019
Q1 | $3.41M | Buy |
102,787
+17,100
| +20% | +$568K | 0.01% | 745 |
|
|
2018
Q4 | $2.49M | Buy |
85,687
+43,087
| +101% | +$1.25M | 0.01% | 776 |
|
|
2018
Q3 | $1.96M | Sell |
42,600
-27,800
| -39% | -$1.28M | 0.01% | 883 |
|
|
2018
Q2 | $2.63M | Sell |
70,400
-5,900
| -8% | -$220K | 0.01% | 793 |
|
|
2018
Q1 | $2.26M | Buy |
76,300
+8,900
| +13% | +$263K | 0.01% | 830 |
|
|
2017
Q4 | $2.32M | Buy |
+67,400
| New | +$2.32M | 0.01% | 820 |
|
|
2016
Q3 | – | Sell |
-25,900
| Closed | -$793K | – | 1295 |
|
|
2016
Q2 | $793K | Buy |
+25,900
| New | +$793K | ﹤0.01% | 920 |
|
|
2015
Q3 | – | Sell |
-170,600
| Closed | -$5.8M | – | 1486 |
|
|
2015
Q2 | $5.8M | Buy |
170,600
+8,200
| +5% | +$279K | 0.02% | 557 |
|
|
2015
Q1 | $5.75M | Sell |
162,400
-70,020
| -30% | -$2.48M | 0.02% | 559 |
|
|
2014
Q4 | $7.92M | Buy |
232,420
+57,576
| +33% | +$1.96M | 0.03% | 444 |
|
|
2014
Q3 | $6.74M | Sell |
174,844
-7,890
| -4% | -$304K | 0.03% | 463 |
|
|
2014
Q2 | $7.11M | Sell |
182,734
-11,328
| -6% | -$441K | 0.03% | 468 |
|
|
2014
Q1 | $6.64M | Sell |
194,062
-54,905
| -22% | -$1.88M | 0.03% | 471 |
|
|
2013
Q4 | $5.22M | Sell |
248,967
-15,286
| -6% | -$321K | 0.02% | 514 |
|
|
2013
Q3 | $6.21M | Buy |
264,253
+130,387
| +97% | +$3.06M | 0.03% | 477 |
|
|
2013
Q2 | $3.6M | Buy |
+133,866
| New | +$3.6M | 0.02% | 551 |
|